Sigma® Life Science launches oncology disease model cell lines
21 February 2011 | By kdm communications limited
New cell lines offer cellular models of cancer that are expected to enhance development of drugs for personalised medicine...
List view / Grid view
21 February 2011 | By kdm communications limited
New cell lines offer cellular models of cancer that are expected to enhance development of drugs for personalised medicine...
21 February 2011 | By Roche
Role will focus on disorders such as schizophrenia, neurodegeneration, treatment-resistant depression & neurodevelopment...
21 February 2011 | By AstraZeneca
AstraZeneca joins rivals looking to sidestep tougher rules on imported medicines as Russia drives to support domestic industry...
18 February 2011 | By GE Healthcare
Kieran Murphy succeeds retiring Peter Ehrenheicurrent as Life Sciences President and CEO on 31 July 2011...
17 February 2011 | By kdm communications limited
Sigma Life Science, today announced the release of OligoArchitect™...
17 February 2011 | By Novartis
Novartis announced that effective March 2, Naomi Kelman is appointed Head of the Novartis OTC Division...
16 February 2011 | By Roche
The phase III study will investigate a subcutaneous formulation of MabThera for patients with non-Hodgkin’s lymphoma...
16 February 2011 | By Hudson Robotics, Inc.
Hudson is working with distributors and end users across Europe to bring its valued lab solutions to the European market...
15 February 2011 | By The Scott Partnership
Award recognises its role as the world's leading provider of analytical light scattering instrumentation...
15 February 2011 | By kdm communications
Tecan and SciRobotics announced the launch of the integrated Pickolo colony-picker for the Freedom EVO® liquid handling platforms...
15 February 2011 | By NSF
NSF has acquired Pharmalytica Services, a pharmaceutical contract laboratory based in Connecticut...
14 February 2011 | By The Scott Partnership
Preclinical Oncology Services Limited (PRECOS) has doubled its capacity to support the strategic growth of the company...
14 February 2011 | By GDS International
What are the strategies for reducing drug attrition rates in the clinic through the application of transgenic rodent models?...
14 February 2011 | By Adessi
Clondalkin Group has appointed Paul Peach to support its growth strategy within pharmaceuticals and healthcare...
14 February 2011 | By Integra Communications Ltd
A significant number of new, innovative pharmaceutical companies could emerge from the releasing of talented Pfizer scientists...